LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
LLY's diluted EPS for 2025 was $22.95, up 96.0% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 5, 2026
| Diluted EPS (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $29.80 | +94.8% | 27.6% | 26.1% |
| Diluted EPS (TTM) | $29.80 |
|---|---|
| YoY | +94.8% |
| 5-year CAGR | 27.6% |
| 10-year CAGR | 26.1% |
Diluted EPS
| Period | EPS | YoY |
|---|---|---|
| 2025 | $22.95 | +96.0% |
| 2024 | $11.71 | +101.9% |
| 2023 | $5.80 | −15.9% |
| 2022 | $6.90 | +12.7% |
| 2021 | $6.12 | −9.9% |
| 2020 | $6.79 | −23.6% |
| 2019 | $8.89 | +184.0% |
| 2018 | $3.13 | — |
| 2017 | −$0.19 | −107.4% |
| 2016 | $2.58 | +14.2% |
| 2015 | $2.26 | +1.3% |
| 2014 | $2.23 | −48.4% |
| 2013 | $4.32 | +18.0% |
| 2012 | $3.66 | −6.2% |
| 2011 | $3.90 | −14.8% |
| 2010 | $4.58 | +16.2% |
| 2009 | $3.94 | — |
| 2008 | −$1.89 | — |